Notice NOT-DE-23-015 from the NIH Guide for Grants and Contracts

Bachelor’s degree in life science, computer science, bioengineering, bioinformatics, or data management. Responsible for coordinating influx, efflux and storage… $115,000 - $149,000 a year
From Seagen - Wed, 09 Aug 2023 18:09:50 GMT - View all Bothell, WA jobs

Funding Opportunity PAR-23-252 from the NIH Guide for Grants and Contracts. The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R34 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing the treatment gap for individuals with alcohol use disorder (AUD); within this focus, there are five major areas of emphasis: (1) increasing access to treatment for AUD, (2) making treatment for AUD more appealing, (3) examining cost structures and insurance systems, (4) conducting studies on dissemination and implementation of existing evidence-based approaches to treating AUD, and (5) reducing health disparities as a means of addressing the treatment gap in AUD for health disparity populations.

Funding Opportunity PAR-23-251 from the NIH Guide for Grants and Contracts. The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing the treatment gap for individuals with alcohol use disorder (AUD); within this focus, there are five major areas of emphasis: (1) increasing access to treatment for AUD, (2) making treatment for AUD more appealing, (3) examining cost structures and insurance systems, (4) conducting studies on dissemination and implementation of existing evidence-based approaches to treating AUD, and (5) reducing health disparities as a means of addressing the treatment gap in AUD for health disparity populations.

Funding Opportunity PAR-23-250 from the NIH Guide for Grants and Contracts. The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Required mechanism focusing on alcohol treatment and recovery research. This NOFO will focus broadly on topics relevant for treatment of and recovery from alcohol use disorder (AUD), including: medications development, precision medicine, behavioral therapies and mechanisms of behavioral change (MOBC), recovery, translational research, and innovative methods and technologies for AUD treatment and recovery.

Funding Opportunity PAR-23-249 from the NIH Guide for Grants and Contracts. The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R34 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing the treatment gap for individuals with alcohol use disorder (AUD); within this focus, there are five major areas of emphasis: (1) increasing access to treatment for AUD, (2) making treatment for AUD more appealing, (3) examining cost structures and insurance systems, (4) conducting studies on dissemination and implementation of existing evidence-based approaches to treating AUD, and (5) reducing health disparities as a means of addressing the treatment gap in AUD for health disparity populations.

Funding Opportunity RFA-AG-24-045 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites applications to proposehuman studies to better understand thefactors underlying the response variability to exercise training in older adults. This NOFO encourages studies to identify systemic modulators, biomarkers, and other potential mechanisms underlying exercise variation in endpoints that are clinically relevant for older adults. This NOFO also encourages transdisciplinary studies utilizing innovative design methods and analytical approaches combined with clinical phenotyping to disentangle the complicated relationships between endogenous and exogenous factors that drive response variation to exercise. Elucidating factors and mechanisms that underlie variations in exercise response and the extent to which these factors are modifiable may enable more precise and efficacious exercise prescriptions to optimize the clinical efficacy of exercise training in older adults.

Funding Opportunity PAR-23-245 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to advance the development of novel informatics and data science approaches that can help individuals understand and improve their health through actionable insights. NLM seeks applications that further the science of personal health informatics by providing meaningful and actionable insights to individuals through innovative personal health data collection, integration, analysis, and personalized risk assessments and interpretation. Applications seeking to advance the understanding of how informatics tools, systems, and platforms can best present the results, interpretation, and limitations of personalized assessments for the benefit of individuals are encouraged. Applications should include end user engaged approaches and real-world evaluation to inform the design of generalizable, reusable, and scalable personal health informatics tools, systems, and platforms for the benefit of individuals in understanding and improving their health.

Notice NOT-HL-23-102 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-23-243 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research. This FOA is specifically for laboratory-based scientists.The Research Specialist Award is designed to encourage the development of stable research career opportunities for exceptional scientists who want to continue to pursue research within the context of an existing NCI-funded basic, translational, clinical, or population science cancer research program, but not serve as independent investigators. These non-tenure track scientists, such as researchers within a research program, are vital to sustaining the biomedical research enterprise. It is anticipated that only exceptional scientists who want to pursue research within the context of an existing NCI-funded cancer research program, but not serve as independent investigators, will be competitive for this award.

Funding Opportunity PAR-23-242 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research. This FOA is specifically for laboratory-based scientists.The Research Specialist Award is designed to encourage the development of stable research career opportunities for exceptional scientists who want to continue to pursue research within the context of an existing NCI-funded basic, translational, clinical, or population science cancer research program, but not serve as independent investigators. These non-tenure track scientists, such as researchers within a research program, are vital to sustaining the biomedical research enterprise. It is anticipated that only exceptional scientists who want to pursue research within the context of an existing NCI-funded cancer research program, but not serve as independent investigators, will be competitive for this award.

Notice NOT-NS-23-105 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AG-24-029 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites innovative studies that will explore how structural, community, and interpersonal mechanisms operate over the life course among middle aged and older adults to shape health outcomes of Latino/a, Black, Asian, and other first generation immigrant groups in the United States (US) and result in health disparities among these populations. This NOFO also invites innovative studies that will explore data needs and methods when studying the effect of immigration on life course health and Alzheimers disease (AD) and AD-related dementias (ADRD). This NOFO and RFA-AG-24-028 are companion announcements. RFA-AG-24-028 invites Research Project Grant (R01) applications. Applications with preliminary data are encouraged to apply to RFA-AG-24-028, while high-risk/high-payoff projects that lack preliminary data may be more appropriate for this NOFO.

Funding Opportunity RFA-AG-24-028 from the NIH Guide for Grants and Contracts. This notice of funding opportunity (NOFO) invites innovative studies that will explore how structural, community, and interpersonal mechanisms operate over the life course among middle aged and older adults to shape health outcomes of Latino/a, Black, Asian, and other first generation immigrant groups in the United States (US) and result in health disparities among these populations. This NOFO also invites innovative studies that will explore data needs and methods when studying the effect of immigration on life course health and Alzheimers disease (AD) and AD-related dementias (ADRD). High-risk/high-payoff projects that lack preliminary data may be more appropriate for the companion NOFO, RFA-AG-24-029, which invites Exploratory/Developmental Research Grant (R21) applications.

Notice NOT-HG-23-049 from the NIH Guide for Grants and Contracts

Notice NOT-NS-23-104 from the NIH Guide for Grants and Contracts

Notice NOT-NS-23-103 from the NIH Guide for Grants and Contracts

Notice NOT-HL-23-105 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-23-259 from the NIH Guide for Grants and Contracts. Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate translation of scientific discoveries and engineering developments in imaging, data science and/or spectroscopic technologies into methods or tools that address contemporary problems in understanding the fundamental biology, potential risk of development, diagnosis, treatment, and/or disease status for cancer or other disease.

Negotiable: Oxford Nanopore Technologies: Our Applied and Regulated Development team is responsible for the development, optimisation, and verification of products to be used for clinical applications. Oxfordshire, England